These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 15831605

  • 1. Lessons from the management of chronic heart failure.
    McDonagh TA.
    Heart; 2005 May; 91 Suppl 2(Suppl 2):ii24-7; discussion ii31, ii43-8. PubMed ID: 15831605
    [Abstract] [Full Text] [Related]

  • 2. Treatments that improve outcome in the patient with heart failure, left ventricular systolic dysfunction, or both after acute myocardial infarction.
    Weir R, McMurray JJ.
    Heart; 2005 May; 91 Suppl 2(Suppl 2):ii17-20; discussion ii31, ii43-8. PubMed ID: 15831602
    [Abstract] [Full Text] [Related]

  • 3. Importance of in-hospital initiation of evidence-based medical therapies for heart failure-a review.
    Fonarow GC, Gheorghiade M, Abraham WT.
    Am J Cardiol; 2004 Nov 01; 94(9):1155-60. PubMed ID: 15518610
    [Abstract] [Full Text] [Related]

  • 4. Bridging the treatment gap: the secondary care perspective.
    Dancy M.
    Heart; 2005 May 01; 91 Suppl 2(Suppl 2):ii32-4, discussion ii43-8. PubMed ID: 15831609
    [Abstract] [Full Text] [Related]

  • 5. What can we learn from Europe?
    Swedberg K.
    Heart; 2005 May 01; 91 Suppl 2(Suppl 2):ii21-3; discussion ii31, ii43-8. PubMed ID: 15831604
    [Abstract] [Full Text] [Related]

  • 6. Applying standard therapies to new targets: the use of ACE inhibitors and B-blockers for heart failure in adults with congenital heart disease.
    Vonder Muhll I, Liu P, Webb G.
    Int J Cardiol; 2004 Dec 01; 97 Suppl 1():25-33. PubMed ID: 15590076
    [Abstract] [Full Text] [Related]

  • 7. Epidemiology and management of heart failure and left ventricular systolic dysfunction in the aftermath of a myocardial infarction.
    Cleland JG, Torabi A, Khan NK.
    Heart; 2005 May 01; 91 Suppl 2(Suppl 2):ii7-13; discussion ii31, ii43-8. PubMed ID: 15831613
    [Abstract] [Full Text] [Related]

  • 8. Clinical and pharmacologic management of chronic heart failure associated with left ventricular systolic dysfunction.
    Parra D, Marshall R, Soisson K.
    Lippincotts Prim Care Pract; 1999 May 01; 3(3):316-32. PubMed ID: 10711133
    [Abstract] [Full Text] [Related]

  • 9. Improving the management of patients after myocardial infarction, from admission to discharge.
    Amin A.
    Clin Ther; 2006 Oct 01; 28(10):1509-39. PubMed ID: 17157110
    [Abstract] [Full Text] [Related]

  • 10. Switching to evidence-based once-daily beta-blockers for improved adherence to medication across the continuum of post-myocardial infarction left ventricular dysfunction and heart failure.
    Abraham WT.
    Congest Heart Fail; 2008 Oct 01; 14(5):272-80. PubMed ID: 18983291
    [Abstract] [Full Text] [Related]

  • 11. Tissue angiotensin-converting enzyme inhibitors for the prevention of cardiovascular disease in patients with diabetes mellitus without left ventricular systolic dysfunction or clinical evidence of heart failure: a pooled meta-analysis of randomized placebo-controlled clinical trials.
    Saha SA, Molnar J, Arora RR.
    Diabetes Obes Metab; 2008 Jan 01; 10(1):41-52. PubMed ID: 18095949
    [Abstract] [Full Text] [Related]

  • 12. Pharmacologic therapies across the continuum of left ventricular dysfunction.
    Abraham WT, Greenberg BH, Yancy CW.
    Am J Cardiol; 2008 Sep 08; 102(5A):21G-28G. PubMed ID: 18722188
    [Abstract] [Full Text] [Related]

  • 13. [Recent advances and limitations of medical treatment on heart failure].
    Momomura S.
    Kyobu Geka; 2007 Jun 08; 60(6):484-7. PubMed ID: 17564066
    [Abstract] [Full Text] [Related]

  • 14. Drug therapy of chronic heart failure in the elderly: the current state of clinical-trial evidence.
    Dulin BR, Krum H.
    Curr Opin Cardiol; 2006 Jul 08; 21(4):393-9. PubMed ID: 16755210
    [Abstract] [Full Text] [Related]

  • 15. [Temporal trends in pharmacological therapy in the IN-CHF registry from 1995 to 2005].
    Fabbri G, Gorini M, Maggioni AP, Di Lenarda A, Area Scompenso ANMCO, Firenze.
    G Ital Cardiol (Rome); 2007 Feb 08; 8(2):102-6. PubMed ID: 17402354
    [Abstract] [Full Text] [Related]

  • 16. [Therapeutic management of heart failure and left ventricular dysfunction following acute myocardial infarction in French intensive care units].
    Cambou JP, Vicaut E, Papadopoulos-Degrandsart A, Danchin N.
    Ann Cardiol Angeiol (Paris); 2007 Jan 08; 56(1):36-41. PubMed ID: 17343037
    [Abstract] [Full Text] [Related]

  • 17. Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure.
    Lenzen MJ, Boersma E, Reimer WJ, Balk AH, Komajda M, Swedberg K, Follath F, Jimenez-Navarro M, Simoons ML, Cleland JG.
    Eur Heart J; 2005 Dec 08; 26(24):2706-13. PubMed ID: 16183692
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of medical therapy for the reduction of heart failure events in patients with implanted cardioverter defibrillators.
    Pietrasik G, Goldenberg I, McNitt S, Polonsky B, Moss AJ, Zareba W.
    J Cardiovasc Electrophysiol; 2009 Apr 08; 20(4):395-400. PubMed ID: 19017351
    [Abstract] [Full Text] [Related]

  • 19. Improving outcomes in post-acute myocardial infarction heart failure: incorporation of aldosterone blockade into combination therapy to optimize neurohormonal blockade.
    Pitt B, Fonarow GC, Gheorghiade M, Deedwania PC, Duprez DA.
    Am J Cardiol; 2006 May 22; 97(10A):26F-33F. PubMed ID: 16698332
    [Abstract] [Full Text] [Related]

  • 20. Reappraisal of beta-blocker therapy in the acute and chronic post-myocardial infarction period.
    Borrello F, Beahan M, Klein L, Gheorghiade M.
    Rev Cardiovasc Med; 2003 May 22; 4 Suppl 3():S13-24. PubMed ID: 14564230
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.